Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Rolf A. Stahel Emanuela Felley-Bosco Thomas Michael Marti |
| Publication date | October 22, 2007 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |